Perrigo Launches Store Brand Version Of Nicorette® Mini Nicotine Lozenges

  Perrigo Launches Store Brand Version Of Nicorette® Mini Nicotine Lozenges

PR Newswire

ALLEGAN, Mich., Jan. 22, 2013

ALLEGAN, Mich., Jan. 22, 2013 /PRNewswire/ --The Perrigo Company (Nasdaq:
PRGO;TASE) today announced that it has begun shipments of over-the-counter
nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint

(Logo: )

This launch represents the first to market nicotine mini lozenge products for
the store brand market.The mint flavored mini lozenges are marketed under
retailer and wholesalers' store, or own brand labels and are comparable to
GlaxoSmithKline's Nicorette® Mini Lozenge.The product is indicated to reduce
withdrawal symptoms, including nicotine craving, associated with quitting
smoking. "This launch strengthens Perrigo's leading store brand position in
smoking cessation products, which also includes coated and uncoated flavored
gums and regular size lozenges," said Joseph C. Papa, Perrigo's Chairman,
President and Chief Executive Officer. Nicorette® Mini Lozenge is selling at
an annual rate estimated at over $30 million at all retail outlets.

From its beginnings as a packager of generic home remedies in 1887, Perrigo
Company, based in Allegan, Michigan, has grown to become a leading global
provider of quality, affordable healthcare products. The Company develops,
manufactures and distributes over-the-counter ("OTC") and generic prescription
("Rx") pharmaceuticals, nutritional products and active pharmaceutical
ingredients ("API") and is the world's largest manufacturer of OTC
pharmaceutical products for the store brand market. Perrigo's mission is to
offer uncompromised "quality, affordable healthcare products", and it does so
across a wide variety of product categories primarily in the United States,
United Kingdom, Mexico, Israel and Australia, as well as certain other markets
throughout the world, including Canada, China and Latin America. Visit Perrigo
on the Internet (

Note: Certain statements in this press release are forward-looking statements
within the meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and are subject to the safe harbor created thereby. These statements
relate to future events or the Company's future financial performance and
involve known and unknown risks, uncertainties and other factors that may
cause the actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those expressed or
implied by any forward-looking statements. In some cases, forward-looking
statements can be identified by terminology such as "may," "will," "could,"
"would," "should," "expect," "plan," "anticipate," "intend," "believe,"
"estimate," "predict," "potential" or other comparable terminology. The
Company has based these forward-looking statements on its current
expectations, assumptions, estimates and projections. While the Company
believes these expectations, assumptions, estimates and projections are
reasonable, such forward-looking statements are only predictions and involve
known and unknown risks and uncertainties, many of which are beyond the
Company's control. These and other important factors, including those
discussed under "Risk Factors" in the Company's Form 10-K for the year ended
June 30, 2012, as well as the Company's subsequent filings with the Securities
and Exchange Commission, may cause actual results, performance or achievements
to differ materially from those expressed or implied by these forward-looking
statements. The forward-looking statements in this press release are made only
as of the date hereof, and unless otherwise required by applicable securities
laws, the Company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE Perrigo

Contact: Arthur J. Shannon, Vice President, Investor Relations and
Communication, +1-269-686-1709,; Bradley Joseph, Senior
Manager, Investor Relations and Communication, +1-269-686-3373,
Press spacebar to pause and continue. Press esc to stop.